跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 644 条关于
“TVG”
全部
644
临床试验
364
药物
224
机构
7
资讯
49
去年
UK Researchers Begin Clinical Trials for Novel African Swine Fever Vaccine
去年
Tevogen Bio's TVGN 489 Shows Promise in High-Risk COVID-19 Patients
去年
Tevogen's TVGN-489 T Cell Therapy Achieves $9-11 Billion Valuation Following Successful COVID-19 Trial
去年
Tevogen Bio Expands TVGN 489 Pipeline to Include Patients 65 and Older, Targeting $1 Billion Launch Year Revenue
去年
Tevogen Bio Presents ExacTcell Platform to BARDA as Potential Rapid-Response Viral Countermeasure
去年
Tevogen Bio Files Patent for Novel T Cell Vaccine Targeting Entire Viral Genomes
6个月前
Tevogen Bio's AI Platform Achieves Breakthrough in Drug Target Prediction with 92% Accuracy
去年
Tevogen Bio Partners with Databricks to Advance AI-Driven Immunotherapy Target Prediction Platform
去年
Tevogen Bio Secures In-House Cell Therapy Production Facility to Accelerate T Cell Therapeutics Development
2年前
Neuralink's Blindsight Implant Receives FDA Breakthrough Device Designation
第 1 页,共 5 页
上一页
下一页